AlphaCrest Capital Management’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,362
Closed -$505K 329
2022
Q3
$505K Sell
6,362
-21,222
-77% -$1.8M 0.03% 975
2022
Q2
$2.3M Buy
27,584
+22,299
+422% +$1.84M 0.11% 259
2022
Q1
$434K Sell
5,285
-27,152
-84% -$2.13M 0.02% 962
2021
Q4
$2.43M Buy
32,437
+1,620
+5% +$122K 0.09% 328
2021
Q3
$2.33M Sell
30,817
-48,482
-61% -$3.75M 0.12% 230
2021
Q2
$6.13M Buy
79,299
+2,367
+3% +$183K 0.26% 70
2021
Q1
$5.4M Buy
76,932
+58,431
+316% +$4.41M 0.3% 57
2020
Q4
$1.31M Sell
18,501
-9,251
-33% -$581K 0.11% 233
2020
Q3
$1.59M Buy
27,752
+13,129
+90% +$785K 0.17% 133
2020
Q2
$890K Buy
14,623
+1,249
+9% +$77.1K 0.15% 181
2020
Q1
$735K Sell
13,374
-4,349
-25% -$292K 0.09% 402
2019
Q4
$1.28M Sell
17,723
-1,854
-9% -$126K 0.1% 246
2019
Q3
$1.29M Sell
19,577
-4,310
-18% -$277K 0.08% 425
2019
Q2
$1.48M Sell
23,887
-12,371
-34% -$715K 0.13% 238
2019
Q1
$1.96M Buy
36,258
+30,258
+504% +$1.7M 0.3% 53
2018
Q4
$351K Buy
+6,000
New +$376K 0.1% 383

Other funds holding DOX

AlphaCrest Capital Management's DOX Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Amdocs (DOX) in Q4 2022, closing a stake of 6,362 shares — an estimated $505K sold.

AlphaCrest Capital Management first reported a position in DOX in Q4 2018 and held it in 16 quarters. The position peaked at $6.13M in Q2 2021. 460 funds tracked by Wall St. Rank hold DOX as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Amdocs position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 6,362 Amdocs shares in Q4 2022, an estimated $505K.
  • AlphaCrest Capital Management first reported a position in Amdocs in Q4 2018 and held it in 16 quarters.
  • AlphaCrest Capital Management's Amdocs position peaked at $6.13M in Q2 2021.
  • 460 funds tracked by Wall St. Rank held Amdocs as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.